(Q57289945)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

title

Bone marrow transplantation generates T cell-dependent control of myeloma in mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

0 references

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Kate H Gartlan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Pamela Mukhopadhyay

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Antonia Pritchard

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Nicholas D Huntington

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Nicola J Waddell

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

John Miles

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

author name string

Slavica Vuckovic

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

David Smith

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Thomas S Watkins

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Kate A Markey

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Camille Guillerey

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Rachel D Kuns

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Kelly R Locke

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Peter A Johansson

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Antiopi Varelias

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Ping Zhang

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Marta Chesi

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Geoffrey R Hill

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Mark J Smyth

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

language of work or name

English

0 references

publication date

19 November 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Investigation

27 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

volume

129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

page(s)

106-121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

Interleukin 6 is essential for in vivo development of B lineage neoplasms

27 April 2020

cites work

1 reference

12 December 2020

Interferon-gamma in multiple myeloma

1 reference

12 December 2020

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

12 December 2020

An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin

1 reference

12 December 2020

Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors

1 reference

12 December 2020

Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15.

1 reference

12 December 2020

CD34+-selected peripheral blood progenitor cell transplantation in patients with multiple myeloma: tumour cell contamination and outcome

1 reference

12 December 2020

Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow Transplantation

1 reference

12 December 2020

The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells.

1 reference

12 December 2020

Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma

1 reference

12 December 2020

Deregulated cytokine network and defective Th1 immune response in multiple myeloma

1 reference

12 December 2020

Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial

1 reference

12 December 2020

T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cells

1 reference

12 December 2020

Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation

1 reference

12 December 2020

Peripheral blood stem cell contamination evaluated by a highly sensitive molecular method fails to predict outcome of autotransplanted multiple myeloma patients.

1 reference

12 December 2020

Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays

1 reference

12 December 2020

Ex vivo induction of multiple myeloma–specific cytotoxic T lymphocytes

1 reference

12 December 2020

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

12 December 2020

HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells

1 reference

12 December 2020

Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11

1 reference

12 December 2020

Molecular mechanisms whereby immunomodulatory drugs activate natural killer cells: clinical application.

1 reference

12 December 2020

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

1 reference

12 December 2020

Serum interleukin-17 and its relationship to angiogenic factors in multiple myeloma

1 reference

12 December 2020

Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma.

1 reference

12 December 2020

A comparison of allografting with autografting for newly diagnosed myeloma

1 reference

12 December 2020

Immunodeficiency and immunotherapy in multiple myeloma

1 reference

12 December 2020

Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection

1 reference

12 December 2020

AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies.

1 reference

12 December 2020

Comparison of twin and autologous transplants for multiple myeloma

1 reference

12 December 2020

Therapeutic antitumor efficacy of anti-CD137 agonistic monoclonal antibody in mouse models of myeloma

1 reference

12 December 2020

Role of autologous and allogeneic stem cell transplantation in myeloma

1 reference

12 December 2020

Soluble lymphotoxin is an important effector molecule in GVHD and GVL.

1 reference

12 December 2020

ELECTROPHORETIC PATTERNS OF NORMAL AND PATHOLOGICAL HUMAN BLOOD SERUM AND PLASMA.

1 reference

12 December 2020

Prognostically significant cytotoxic T cell clones are stimulated after thalidomide therapy in patients with multiple myeloma

1 reference

12 December 2020

LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study

1 reference

12 December 2020

Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma

1 reference

12 December 2020

Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+ T cell dysfunction in melanoma patients

1 reference

12 December 2020

Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

1 reference

12 December 2020

Selection of CD8+PD-1+ lymphocytes in fresh human melanomas enriches for tumor-reactive T cells

1 reference

12 December 2020

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised p

1 reference

12 December 2020

The transcription factor PlagL2 activates Mpl transcription and signaling in hematopoietic progenitor and leukemia cells

1 reference

12 December 2020

Fate mapping of IL-17-producing T cells in inflammatory responses

1 reference

12 December 2020

Bias in the αβ T-cell repertoire: implications for disease pathogenesis and vaccination

1 reference

12 December 2020

Long-term prognostic significance of response in multiple myeloma after stem cell transplantation.

1 reference

12 December 2020

Current trends in autologous stem-cell transplantation for myeloma in the era of novel therapies

1 reference

12 December 2020

The IL-17 differentiation pathway and its role in transplant outcome

1 reference

12 December 2020

Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy

1 reference

12 December 2020

Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis

1 reference

12 December 2020

The genetic architecture of multiple myeloma.

1 reference

12 December 2020

Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry.

1 reference

12 December 2020

Molecular pathogenesis of multiple myeloma and its premalignant precursor

1 reference

12 December 2020

Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance

1 reference

12 December 2020

Discovery and saturation analysis of cancer genes across 21 tumour types

1 reference

12 December 2020

Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy

1 reference

12 December 2020

New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape

1 reference

12 December 2020

Combination anti-CD137 and anti-CD40 antibody therapy in murine myc-driven hematological cancers.

1 reference

12 December 2020

Potential relationship and clinical significance of miRNAs and Th17 cytokines in patients with multiple myeloma.

1 reference

12 December 2020

Innate immunodeficiency following genetic ablation of Mcl1 in natural killer cells.

1 reference

12 December 2020

Critical role of Spns2, a sphingosine-1-phosphate transporter, in lung cancer cell survival and migration

1 reference

12 December 2020

Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial.

1 reference

12 December 2020

Alkylating agent melphalan augments the efficacy of adoptive immunotherapy using tumor-specific CD4+ T cells

1 reference

12 December 2020

Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantation

1 reference

12 December 2020

Overcoming T cell exhaustion in infection and cancer

1 reference

12 December 2020

Immunosurveillance and therapy of multiple myeloma are CD226 dependent

1 reference

12 December 2020

Boosting Cancer Immunotherapy with Anti-CD137 Antibody Therapy.

1 reference

12 December 2020

Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myeloma

1 reference

12 December 2020

Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies

1 reference

12 December 2020

Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade.

1 reference

12 December 2020

Spontaneous onset and transplant models of the Vk*MYC mouse show immunological sequelae comparable to human multiple myeloma.

1 reference

12 December 2020

Novel functions for the transcription factor E2F4 in development and disease

1 reference

12 December 2020

Acute graft-versus-host disease is regulated by an IL-17-sensitive microbiome.

1 reference

12 December 2020

Chromatin states define tumour-specific T cell dysfunction and reprogramming.

1 reference

12 December 2020

High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma

1 reference

12 December 2020

Myeloma escape after stem cell transplantation is a consequence of T-cell exhaustion and is prevented by TIGIT blockade

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI98888

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30300141%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

PubMed publication ID

30300141

1 reference